BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical long-term study
Lund, Sweden, 15.00 CET, 14 April 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that new preclinical data[1] has been published that further support BONESUPPORT’s ambition to develop a combination product of the company’s platform technology CERAMENT® and bisphosphonate, a pharmaceutical that counteracts osteoporosis. In a pre-clinical long-term study D.B. Raina et al. investigated different bone active pharmaceutical combinations in order to enhance long-term bone formation in the femoral neck of osteoporotic rats. Bone